MoonLake Immunotherapeutics (MLTX) offers strong investment potential with key clinical trials and upcoming FDA milestones.

Te Whatu Ora is standardising oral health data and planning to consolidate dental practice management systems to enable ...

Scientific interest in cannabis has accelerated at an unprecedented pace, with 2025 producing more peer-reviewed research ...

Carina Health Network execs discuss success in MSSP and the network’s clinical and technology priorities for 2026 ...

As hospitals and health systems continue to grapple with revenue leakage and clinical denials, many are turning to innovative technologies to bridge the gap between payers and providers. Organizations ...

To keep up with COPD research and care developments, the 2026 Global Initiative for Chronic Obstructive Lung Disease report ...

Beacon Biosignals, known for its sleep monitoring system, hauled in $86 million as part of an oversubscribed series B funding ...

“Endotyping-informed therapy in the MRI-guided intervention arm led to a reduction in angina burden and an improvement in health-related quality of life,” reported the principal investigator Colin ...

Interest in ivermectin for kidney cancer has come primarily from preclinical studies. Authors of a review from China stated ...

P3 Health Partners Inc. (NASDAQ: PIII) Q3 2025 Earnings Call Transcript November 14, 2025 P3 Health Partners Inc. misses on ...

There is no doubt artificial intelligence (AI) has the potential to improve access to mental health care. “One could imagine ...